Promising results from the 1b portion, albeit a bit hard to interpret.
What doesn't quite make sense to me is why only 3 remain on trial, if results were so positive. @vrs37 any thoughts?
Pretty happy with the enrolment rates in 2a.
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-11
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.0¢ | $20.04K | 130.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 104907 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 23481 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |